| scholarly article | Q13442814 |
| P2093 | author name string | D. T. Purtilo | |
| P433 | issue | 8163 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 300-303 | |
| P577 | publication date | 1980-02-01 | |
| 1980-02-09 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals | |
| P478 | volume | 1 |
| Q45799934 | A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition |
| Q39527491 | Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study |
| Q40853219 | Angioimmunoblastic lymphadenopathy after infectious mononucleosis |
| Q72441183 | Anti-endorphin effects of methadone |
| Q72477224 | Axillary or rectal temperatures in children? |
| Q45798932 | Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome |
| Q35832561 | Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency. |
| Q61718416 | Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells |
| Q41563745 | Chronic Antigenic Stimulation from the Graft as a Possible Oncogenic Factor after Renal Transplant |
| Q34254852 | Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine |
| Q47209601 | Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America |
| Q53510088 | Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association. |
| Q40077580 | Current Understanding of Virus Etiology in Leukemia |
| Q40302782 | Cutaneous manifestations of paraproteinaemia. Part II. |
| Q45806678 | Cyclosporin A and Epstein-Barr virus |
| Q45802718 | Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines |
| Q72441192 | Cyclosporin A, transplantation, and lymphoma |
| Q70302612 | Cyclosporin a: Pharmacologic activity on the immune system and effects in clinical organ transplantation |
| Q36996658 | Cytomegalovirus and Langerhans Cell Histiocytosis: Is There a Link? |
| Q40327589 | Depressed immunity and the development of cancer. |
| Q36560541 | Detection of Epstein-Barr Virus DNA in Langerhans Cell Histiocytosis |
| Q72558404 | Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient |
| Q45807003 | Diagnosis of Hodgkin's disease hampered by an Epstein-Barr virus infection treated with acyclovir |
| Q44715642 | Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients |
| Q36508964 | EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression |
| Q43468003 | Effect of cyclosporin a on the production of interferon by human peripheral blood leukocytes in vitro |
| Q39510505 | Epstein-Barr virus-associated malignancies |
| Q45779365 | Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach |
| Q44291054 | Epstein-Barr-virus-carrying lymphoma in cardiac transplant recipient |
| Q45805778 | Epstein-Barr-virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect |
| Q40126396 | Epstein-barr virus and human disease: Immune responses determine the clinical and pathologic expression |
| Q44452775 | Epstein-barr virus-induced lymphoma in a cardiac transplant recipient |
| Q70160327 | Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A |
| Q35885953 | Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias |
| Q72895786 | Fatal lymphoproliferation and acute monocytic leukemia-like disease following infectious mononucleosis in the elderly |
| Q45779528 | Gastric adenocarcinoma with differentiation to sarcomatous components associated with monoclonal Epstein-Barr virus infection and LMP-1 expression |
| Q45935211 | HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. |
| Q39518791 | Haematological abnormalities in human immunodeficiency virus (HIV) disease |
| Q54094400 | Herpes Simplex Virus and Langerhans Cell Histiocytosis. |
| Q33371209 | Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. |
| Q42492863 | Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia |
| Q41552231 | Immunopathology of the X-Linked Lymphoproliferative Syndrome |
| Q72434099 | Infectious mononucleosis and acute monocytic leukemia |
| Q40147866 | Invited review. Nervous system antigens |
| Q72477233 | Is histiocytic medullary reticulosis a fatal form of infectious mononucleosis? |
| Q72107822 | Logistics of tumor immunology |
| Q70275218 | Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States—Japan seminar, September 6 and 7, 1982, in Seattle, Washington |
| Q36436908 | Lymphotropic Viruses as Etiologic Agents of Lymphoma |
| Q40795588 | Malignancies in the acquired immunodeficiency syndrome |
| Q40127412 | Malignant lymphoproliferative diseases induced by Epstein-Barr virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes |
| Q70244845 | Malignant tumors in renal transplant patients the scandia transplant material |
| Q72008908 | Masquerading mononucleosis or monocytic leukemia? |
| Q40136777 | Oncological consequences of impaired immune surveillance against ubiquitous viruses |
| Q72396343 | Oral carcinoma: Evidence for viral oncogenesis |
| Q72429145 | Plasma ethanol, endorphin, and glucose experiment |
| Q40839493 | Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. |
| Q69521617 | Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation |
| Q37111224 | Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome |
| Q37153548 | Principal neuropathological and general necropsy findings in 24 renal transplant patients |
| Q45861036 | Raised serum thyroxine in patient on haemophilia therapy |
| Q35835313 | Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. |
| Q40137308 | Sexually transmitted viral infections in homosexual men. |
| Q33396983 | The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation |
| Q40093859 | The Leeuwenhoek Lecture, 1983 A prototype vaccine to prevent Epstein-Barr virus-associated tumours |
| Q43529834 | The Pathogenesis of Infectious Mononucleosis |
| Q36444901 | The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990. |
| Q77740355 | The antiviral prophylaxis of post-transplant lymphoproliferative disorder |
| Q37549340 | The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal |
| Q43530789 | The falling incidence of hematologic cancer after heart transplantation. |
| Q36660525 | The kissing virus |
| Q70425853 | The occurrence of cancer in immune deficiencies |
| Q35830515 | The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study |
| Q41615761 | Treatment of organ transplant-related lymphoma |
| Q52078643 | Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation. |
| Q70165756 | Viral infections in immunocompromised patients |
| Q39480322 | Virus-induced immunosuppression |
| Q40138083 | Viruses and cancer: Herpesviruses and tumors in the head and neck |
| Q36464546 | X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology |
| Q68902793 | [Hodgkin's disease following kidney transplantation with cyclosporin A] |
Search more.